Literature DB >> 24618938

Measles seropositivity in HIV-infected Kenyan children on antiretroviral therapy.

Laura P Newman1, Anne Njoroge, Leila Ben-Youssef, Michele Merkel, Ann Gatuguta, Quy Ton, Elizabeth Maleche Obimbo, Dalton Wamalwa, Barbara Lohman-Payne, Barbra A Richardson, Ruth Nduati, Carey Farquhar.   

Abstract

This article describes results from a cross-sectional study among HIV-infected children 15 months to 12 years of age who were receiving antiretroviral therapy. We found a low prevalence of measles IgG seropositivity (45.7%) and identified CD4% ≥ 25 as a predictor. Most HIV-infected children on ART were not measles seropositive and might benefit from revaccination.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24618938      PMCID： PMC4160422          DOI： 10.1097/INF.0000000000000332

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  8 in total

1.  Measles antibody: reevaluation of protective titers.

Authors:  R T Chen; L E Markowitz; P Albrecht; J A Stewart; L M Mofenson; S R Preblud; W A Orenstein
Journal:  J Infect Dis       Date:  1990-11       Impact factor: 5.226

2.  Prevalence of protective antibody against measles in HIV-infected children with immune recovery after highly active antiretroviral therapy.

Authors:  L Aurpibul; T Puthanakit; S Siriaksorn; T Sirisanthana; V Sirisanthana
Journal:  HIV Med       Date:  2006-10       Impact factor: 3.180

Review 3.  Vaccines for measles, mumps and rubella in children.

Authors:  Vittorio Demicheli; Alessandro Rivetti; Maria Grazia Debalini; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

4.  Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy.

Authors:  Mark J Abzug; Min Qin; Myron J Levin; Terence Fenton; Judy A Beeler; William J Bellini; Susette Audet; Sun Bae Sowers; William Borkowsky; Sharon A Nachman; Stephen I Pelton; Howard M Rosenblatt
Journal:  J Infect Dis       Date:  2012-06-12       Impact factor: 5.226

5.  EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia.

Authors:  Simonetta Viviani; Maimuna Mendy; Abdoulie D Jack; Andrew J Hall; Ruggero Montesano; Hilton C Whittle
Journal:  Trop Med Int Health       Date:  2004-10       Impact factor: 2.622

6.  Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody.

Authors:  S Ratnam; V Gadag; R West; J Burris; E Oates; F Stead; N Bouilianne
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

7.  Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination.

Authors:  Carey Farquhar; Dalton Wamalwa; Sara Selig; Grace John-Stewart; Jennifer Mabuka; Maxwel Majiwa; William Sutton; Nancy Haigwood; Grace Wariua; Barbara Lohman-Payne
Journal:  Pediatr Infect Dis J       Date:  2009-04       Impact factor: 2.129

8.  Measles outbreak in Africa--is there a link to the HIV-1 epidemic?

Authors:  Anna Nilsson; Francesca Chiodi
Journal:  PLoS Pathog       Date:  2011-02-10       Impact factor: 6.823
  8 in total
  4 in total

1.  Sustained Responses to Measles Revaccination at 24 Months in HIV-infected Children on Antiretroviral Therapy in Kenya.

Authors:  Laura P Newman; Anne Njoroge; Amalia Magaret; Bhavna H Chohan; Veronicah W Gitomea; Anna Wald; Jonathan Gorstein; Julie Overbaugh; Dalton Wamalwa; Elizabeth Maleche-Obimbo; Ruth Nduati; Carey Farquhar
Journal:  Pediatr Infect Dis J       Date:  2017-12       Impact factor: 2.129

2.  Measles and Rubella Seroprevalence Among HIV-infected and Uninfected Zambian Youth.

Authors:  Catherine G Sutcliffe; Kelly Searle; Hellen K Matakala; Michelle P Greenman; Kaitlin Rainwater-Lovett; Philip E Thuma; William J Moss
Journal:  Pediatr Infect Dis J       Date:  2017-03       Impact factor: 2.129

3.  T cell anergy and activation are associated with suboptimal humoral responses to measles revaccination in HIV-infected children on anti-retroviral therapy in Nairobi, Kenya.

Authors:  M B Buechler; L P Newman; B H Chohan; A Njoroge; D Wamalwa; C Farquhar
Journal:  Clin Exp Immunol       Date:  2015-07-02       Impact factor: 4.330

4.  Safety and Immunogenicity of Measles Vaccination in HIV-Infected and HIV-Exposed Uninfected Children: A Systematic Review and Meta-Analysis.

Authors:  Eleonora A M L Mutsaerts; Marta C Nunes; Martijn N van Rijswijk; Kerstin Klipstein-Grobusch; Diederick E Grobbee; Shabir A Madhi
Journal:  EClinicalMedicine       Date:  2018-07-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.